QGEN: Utang marang Ekuitas qiagen.com

Logo grafis Qiagen N.V. (QGEN)

Qiagen N.V. (QGEN) is competing for the laboratory market against industry behemoths, leveraging demand within the DNA sequencing segment. The leverage ratio demonstrates financial stability, where a metric value of 0.48 confirms a balanced liability structure. High barriers to entry, driven by exclusive patents and stringent FDA oversight, ensure long-term business protection.

QGEN: Total Utang marang Modal Qiagen 04.07.2022 - 01.11.2026
Produk dadi Qiagen Corp

Steady demand for Qiagen N.V. (QGEN) consumables allows the company to flexibly manage its debt load. This metric compares total liabilities to equity, determining the degree of financial leverage. By analyzing the historical changes in the total debt-to-equity ratio, an investor assesses bankruptcy risk and borrowing efficiency. Reducing leverage minimizes business vulnerability, while an optimal balance ensures capitalization stability.

Pesaing Qiagen N.V. (QGEN)

TEM (tempus.com) - Total Utang marang Modal|Rasio Utang marang Ekuitas IONS (Ionis Pharmaceuticals, Inc.)|Utang marang Ekuitas Repligen Corp. (RGEN)|Avidity Corp - Rasio Utang marang Ekuitas|Total Utang marang Modal CRSP (CRISPR Therapeutics AG)|Total Utang marang Modal genedx.com WGS|RARE - Utang marang Ekuitas|Rasio Utang marang Modal Beam Therapeutics Inc (BEAM)|SRPT: Total Utang marang Modal|TWST - Koefisien Total Utang marang Modal|TXG (10x Genomics, Inc.) - Total Utang marang Modal|Total Utang marang Modal intelliatx.com|Total Utang marang Modal STOK|BioLife Solutions Inc (BLFS) - Rasio Utang marang Modal|Total Utang marang Modal WVE (Wave Life Sciences Corp)|Maze Therapeutics Corp (MAZE) - Utang marang Modal|SION - Utang marang Ekuitas|PRME (primemedicine.com) - Rasio Utang marang Ekuitas|TSHA (Taysha Gene Therapies, Inc.) - Rasio Total Utang marang Ekuitas|uniQure NV - Rasio Kabeh Utang marang Dana Pribadi|Utang marang Ekuitas MeiraGTx PLC|Rasio Utang marang Ekuitas RGNX (REGENXBIO Corp)|Rasio Total Utang marang Ekuitas SLDB (Solid Biosciences Inc.)|Koefisien Total Utang marang Modal ocugen.com|PacBio - Rasio Total Utang marang Ekuitas|Benitec Biopharma Inc - Utang marang Ekuitas|DSGN: Rasio Total Utang marang Ekuitas|Koefisien Total Utang marang Modal Rocket Corp RCKT|4D Molecular Therapeutics (FDMT) - Utang marang Ekuitas|Rasio Utang marang Modal Lexeo Therapeutics, Inc. LXEO|KRRO (Korro Bio Inc.) - Total Utang marang Modal|EDIT - Rasio Utang marang Modal|Total Utang marang Modal SLN|PRQR - Utang marang Modal|Utang marang Ekuitas Codexis CDXS|SGMO: Rasio Utang marang Ekuitas|Nautilus Biotechnology Inc - Total Utang marang Modal|MGX (Metagenomi Inc.) - Rasio Utang marang Ekuitas|Precision BioSciences, Inc. (DTIL) - Utang marang Ekuitas|Rasio Utang marang Ekuitas GBIO|BOLD (Boundless Bio, Inc.) - Total Utang marang Modal|Total Utang marang Modal Exicure Corp|Utang marang Ekuitas Imunon, Inc. (IMNN)|phiopharma.com (PHIO) - Rasio Utang marang Modal|Total Utang marang Modal MBIO (Mustang Bio)|Koefisien Total Utang marang Modal TransCode Therapeutics Inc. (RNAZ)|Bionano - Total Utang marang Modal|APDN - Total Utang marang Modal|BLUE: Total Utang marang Modal|Rasio Utang marang Modal ImmunoPrecise Antibodies Ltd. IPA|OMGA (Omega) - Total Utang marang Modal|Utang marang Modal Singular Genomics Corp OMIC|Utang marang Ekuitas Regulus Therapeutics (RGLS)|syros.com - Rasio Utang marang Ekuitas|Telesis Bio - Rasio Total Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi TCON|UBX - Utang marang Ekuitas